Deciphering the nanomaterial uptake in a bystander manner invoked by co-administration of functionalized nanoparticles
以旁观者的方式破译由功能化纳米颗粒共同施用引起的纳米材料吸收
基本信息
- 批准号:10005420
- 负责人:
- 金额:$ 30.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:Amino AcidsBindingCaliberCell Surface ReceptorsCell membraneCell physiologyCell surfaceCellsCellular biologyComplexCoupledCysteineDiagnosisDrug Delivery SystemsEndocytosisEnvironmentGene DeliveryGeneticGenetic ScreeningGenetic TranscriptionGoalsHeparan Sulfate ProteoglycanHeparitin SulfateLigandsLightLinkLiquid substanceMediatingMembraneMetabolicMetabolismMethodsMolecular ProfilingNanotechnologyNutrientPathway interactionsPeptidesPlayProcessPropertyRNA interference screenRegulationResearchRoleSignal TransductionSiteSulfateTissuesVacuoleValidationVesicleextracellulargenome-widehuman diseasein vivoinsightnanomaterialsnanoparticlenanoparticle deliverynanoscalenovelparticlereceptorsynergismuptake
项目摘要
Abstract
One important yet understudied aspect in nanomaterial applications is the cell biology of nanomaterial
transport into cells and through tissues. To overcome the cell membranes and reach their sites of action
within, nanoparticles (NPs) are often complexed with cell-penetrating ligands. Such ligands include peptides
like TAT (Trans-Activating Transcription). These ligands engage with cell surface receptors to invoke
endocytic processes for NP uptake. However, the impact of these functionalized NPs and the resulting
endocytic process on the cellular uptake of other NPs remains unknown. In this proposal, I aim to tackle this
problem by studying TAT-coupled NPs (TAT-NP).
By tracing NPs coated with several cell-penetrating peptides, including TAT, we previously discovered a
novel receptor-dependent macropinocytosis (MP) pathway for NP uptake. MP has relatively large endocytic
vacuoles (>200 nm in diameter) and thus can more readily engulf cargo as large as nanoparticles. Here, we
found that TAT-NPs, by invoke this MP pathway, can bring into cells bystander NPs that are unable to enter
the cells by themselves. This bystander uptake depends on TAT interaction with its receptor, heparan sulfate
(HS) proteoglycans, and occurs through the HS-dependent MP pathway. We further showed that it is only
active for NP-type bystander cargo, and its activity is greatly stimulated by Cysteine (Cys) outside the cells.
Here, we aim to dissect out this bystander uptake process. In the Aim 1, we will determine the prerequisites
for initiating the bystander uptake. In the Aim 2 and 3, we will utilize genetic screening and other methods to
determine the factors that mediate this bystander uptake, and define its properties of cargo selectivity and
Cys regulation. In the Aim 4, we will explore the potential use in biomedical applications. My proposed
studies hold great potential for unveiling important cellular machineries for nanomaterial transport, boosting
the efficiency of intracellular delivery, and opening up a new avenue to study cell biology, metabolism and
nanomaterial delivery.
摘要
纳米材料的细胞生物学是纳米材料应用中一个重要但尚未充分研究的方面
运输到细胞和通过组织。克服细胞膜到达它们的作用部位
其中,纳米颗粒(NP)通常与细胞穿透配体复合。这样的配体包括肽
比如达特(Trans-Activating Transcription)。这些配体与细胞表面受体结合,
NP摄取的内吞过程。然而,这些官能化NP的影响和由此产生的纳米颗粒的性质是不确定的。
其他NP的细胞摄取的内吞过程仍然未知。在这份建议中,我的目标是解决这个问题
本文通过对TAT耦合NP(TAT-NP)的研究,提出了一个新的问题。
通过追踪包被有几种细胞穿透肽(包括达特)的纳米颗粒,我们先前发现了一种新的细胞穿透肽。
NP摄取的新型受体依赖性巨胞饮(MP)途径。MP具有相对大的内吞作用,
空泡(直径>200 nm),因此可以更容易地吞噬与纳米颗粒一样大的货物。这里我们
发现TAT-NPs通过激活MP通路,可以将无法进入细胞的旁观者NPs带入细胞
细胞本身。这种旁观者摄取依赖于达特与其受体硫酸乙酰肝素的相互作用
(HS)蛋白聚糖,并通过HS依赖性MP途径发生。我们进一步表明,它只是
对NP型旁观者货物有活性,并且其活性被细胞外的半胱氨酸(Cys)极大地刺激。
在这里,我们的目标是剖析这个旁观者吸收过程。在目标1中,我们将确定
启动旁观者摄取。在目标2和3中,我们将利用基因筛选和其他方法,
确定介导这种旁观者摄取的因素,并确定其货物选择性的性质,
Cys调节。在目标4中,我们将探索在生物医学应用中的潜在用途。我建议的
研究具有很大的潜力,可以揭示纳米材料运输的重要细胞机制,
细胞内传递的效率,并开辟了一条新的途径,研究细胞生物学,代谢和
纳米材料输送。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hongbo Pang其他文献
Hongbo Pang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hongbo Pang', 18)}}的其他基金
Deciphering the nanomaterial uptake in a bystander manner invoked by co-administration of functionalized nanoparticles
以旁观者的方式破译由功能化纳米颗粒共同施用引起的纳米材料吸收
- 批准号:
10170384 - 财政年份:2019
- 资助金额:
$ 30.42万 - 项目类别:
Deciphering the nanomaterial uptake in a bystander manner invoked by co-administration of functionalized nanoparticles
以旁观者的方式破译由功能化纳米颗粒共同施用引起的纳米材料吸收
- 批准号:
10403647 - 财政年份:2019
- 资助金额:
$ 30.42万 - 项目类别:
Improving the in Vivo Delivery and Antitumor Efficacy of Antisense Drugs
提高反义药物的体内递送和抗肿瘤功效
- 批准号:
9761470 - 财政年份:2017
- 资助金额:
$ 30.42万 - 项目类别:
Improving the in Vivo Delivery and Antitumor Efficacy of Antisense Drugs
提高反义药物的体内递送和抗肿瘤功效
- 批准号:
10219981 - 财政年份:2017
- 资助金额:
$ 30.42万 - 项目类别:
Improving the in vivo delivery and antitumor efficacy of antisense drugs
提高反义药物的体内递送和抗肿瘤功效
- 批准号:
9289598 - 财政年份:2017
- 资助金额:
$ 30.42万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321481 - 财政年份:2024
- 资助金额:
$ 30.42万 - 项目类别:
Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321480 - 财政年份:2024
- 资助金额:
$ 30.42万 - 项目类别:
Continuing Grant
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
- 批准号:
DP240103289 - 财政年份:2024
- 资助金额:
$ 30.42万 - 项目类别:
Discovery Projects
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 30.42万 - 项目类别:
Fellowship
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
- 批准号:
EP/X039420/1 - 财政年份:2024
- 资助金额:
$ 30.42万 - 项目类别:
Research Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
- 批准号:
2317664 - 财政年份:2024
- 资助金额:
$ 30.42万 - 项目类别:
Standard Grant
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
- 批准号:
2419915 - 财政年份:2024
- 资助金额:
$ 30.42万 - 项目类别:
Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 30.42万 - 项目类别:
Research Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
- 批准号:
2347997 - 财政年份:2024
- 资助金额:
$ 30.42万 - 项目类别:
Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 30.42万 - 项目类别:
Discovery Projects